NEO - NeoGenomics Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (%) TVIX (%) TLRA (%) RKDA (-8.29%) PYPL (%) PG (0.89%) PFE (1.53%) NVS (0.02%) MSFT (1.68%) MRK (1.33%) MCD (0.15%) JMIA (17.91%) IRBT (2.46%) GOOGL (1.8%) GE (-1.37%) FB (1.35%) ETHUSD (%) EKSO (0%) DIS (0.07%) CVX (1.3%) CVNA (-2.9%) BTCUSD (%) BBY (1.2%) BAC (0.89%) AVB (0.91%)

We Think NeoGenomics (NASDAQ:NEO) Can Ma...	08/12/19
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Neo Performance Materials, Inc. to Host ...	08/12/19
NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Neo Performance Materials, Inc. (NASDAQ: NEO ) will be discussing their earnings results in their 2019 S...

NeoGenomics Announces Leadership Transit...	08/08/19
FT. MYERS, FL / ACCESSWIRE / August 8, 2019 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, this morn...

Here's Why Genetic Testing Stocks R...	08/05/19
It was a great month to be a genetic testing company.

Edited Transcript of NEO earnings confer...	08/02/19
Q2 2019 Neogenomics Inc Earnings Call

IBD Stock Of The Day With 93% Gain This ...	08/01/19
NeoGenomics stock is the IBD Stock Of The Day as the cancer-testing outlet breaks out on a never-higher relative strength line. Earlier this week, Neo...

NEO Breaks Out	08/01/19
Cancer testing firm NeoGenomics broke out Thursday from a flat base, a couple of days after reporting strong earnings. NEO is stock of the day. Many c...

NeoGenomics Announces Grand Opening of N...	07/31/19
FORT MYERS, FL and WILMINGTON, NC / ACCESSWIRE / July 31, 2019 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetics testing servi...

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$25.24	Open	$25.67
Volume	1.06M	Market Cap	2.043B
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

NEO - NeoGenomics

$25.51 0.27[1.07%]

Add to New List:

Day

52 Week

ANALYST RATINGS

100.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $NEO

About Us

Product Types

Strategies

Follow Us

Secure Payments

Strong Buy rating	07/31/19
Raymond James maintains Outperform rating and raises Price Target from $23.00 to $27.00